This list shows the 10 top penny stock gainers of March 2017, which we'll be keeping an eye on in April to see if they post any more gains...
|Penny Stock||Current Price||March 2017 Gain|
|Ocera Therapeutics Inc. (Nasdaq: OCRX)||$1.26||+98.5%|
|Cancer Genetics Inc. (Nasdaq: CGIX)||$3.90||+82.2%|
|Verastem Inc. (Nasdaq: VSTM)||$2.02||+81.6%|
|Catalyst Pharmaceuticals Inc. (Nasdaq: CPRX)||$1.92||+72.6%|
|Imprimis Pharmaceuticals Inc. (Nasdaq: IMMY)||$4.01||+70.9%|
|Internap Corp. (Nasdaq: INAP)||$3.73||+65.3%|
|Performant Financial Corp. (Nasdaq: PFMT)||$2.87||+62.8%|
|Highpower International Inc. (Nasdaq: HPJ)||$4.15||+61.2%|
|Pain Therapeutics Inc. (Nasdaq: PTIE)||$0.84||+56.1%|
|Microvision Inc. (Nasdaq: MVIS)||$2.40||+55.6%|
The best penny stock of March 2017 was Ocera Therapeutics Inc. with a 98.5% return. That crushed broader indexes like the Dow Jones Industrial Average and S&P 500, which gained 0.2% and lost 0.2% last month, respectively.
Penny Stock Profits: This investing strategy has generated total peak gains of 17,781% over the last five years, targeting little-known penny stocks backed by America's richest investors. Read more...
But remember, this list simply tracks the top stocks trading under $5 a share on the SEC-regulated Nasdaq exchange. Although these penny stocks are safer than the unregulated ones trading on the pink sheets, you shouldn't buy them without first doing extensive research. This can include examining the company's CEO compensation and other finances included in its 10-K filing.
Conducting this research can be an arduous task, especially if you're unfamiliar with company documents. A 10-K filing can be hundreds of pages long and contain mundane language that only the company's accountants understand.
That's why Money Morning Small-Cap Specialist Sid Riggs has already done the research and found one of the best small-cap stocks to buy right now. He likes this company for two reasons...
- It boasts more than 10,000 customers across several booming markets like healthcare and banking.
- It has a dominant position in the high-growth financial cybersecurity sector.
Not to mention analysts expect it to soar as much as 53.8% over the next 12 months.
Here's the one stock you must consider today...